Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2026-01-13 @ 5:14 PM
Study NCT ID:
NCT06343805
Status:
RECRUITING
Last Update Posted:
2025-12-24
First Post:
2024-03-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
Sponsor:
Ajax Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-10-23
Start Date Type:
ACTUAL
Primary Completion Date:
2026-10-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-02-15
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-13
First Submit QC Date:
None
Study First Post Date:
2024-04-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-18
Last Update Post Date:
2025-12-24
Last Update Post Date Type:
ACTUAL